| Ticker Details |
|
Nkarta, Inc.
|
| IPO Date: |
July 10, 2020 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$165.5M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.54 | 3.92%
|
| Avg Daily Range (30 D): |
$0.08 | 3.55%
|
| Avg Daily Range (90 D): |
$0.06 | 2.94%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.79M |
| Avg Daily Volume (30 D): |
.75M |
| Avg Daily Volume (90 D): |
.75M |
| Trade Size |
| Avg Trade Size (Sh.): |
128 |
| Avg Trade Size (Sh.) (30 D): |
171 |
| Avg Trade Size (Sh.) (90 D): |
183 |
| Institutional Trades |
| Total Institutional Trades: |
657 |
| Avg Institutional Trade: |
$1.72M |
| Avg Institutional Trade (30 D): |
$1.01M |
| Avg Institutional Trade (90 D): |
$1.08M |
| Avg Institutional Trade Volume: |
.11M |
| Avg Institutional Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.73M |
| Avg Closing Trade (30 D): |
$1.01M |
| Avg Closing Trade (90 D): |
$1.01M |
| Avg Closing Volume: |
112.01K |
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
$-1.37
|
$-.29
|
$-.31
|
|
Diluted EPS
|
$-1.37
|
$-.29
|
$-.31
|
|
Revenue
|
$M
|
$M
|
$M
|
|
Gross Profit
|
|
|
|
|
Net Income / Loss
|
$-102.61M
|
$-21.72M
|
$-22.98M
|
|
Operating Income / Loss
|
$-121.96M
|
$-27.29M
|
$-27.19M
|
|
Cost of Revenue
|
|
|
|
|
Net Cash Flow
|
$3.15M
|
$6.7M
|
$25.54M
|
|
PE Ratio
|
|
|
|
|
|
|